Skip to main content
. 2021 Aug 17;3(3):otab060. doi: 10.1093/crocol/otab060

Figure 1.

Figure 1.

Given are the proportion of CD patients (%) and the total number of patients who underwent endoscopy after start of IFX and who achieved endoscopic remission within 24 months after start of IFX. In total, 61 patients in the early intervention group and 86 patients in the late intervention group underwent endoscopy after start of IFX and 91.8%, respectively, 88.4% of these patients also underwent endoscopy before start of IFX. Abbreviations: CD, Crohn’s disease; IFX, infliximab.